These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 8013792

  • 21. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 22. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
    Laufer G, Laczkovics A, Wollenek G, Schreiner W, Sochor H, Holzinger C, Buchelt M, Fasol R, Wolner E.
    J Heart Transplant; 1989 May; 8(3):253-61. PubMed ID: 2661776
    [Abstract] [Full Text] [Related]

  • 23. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT, Jessen ME, Baldwin BJ, Horn VP, Yancy CW, Ring WS, Rosenblatt RL.
    J Heart Lung Transplant; 1995 May; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [Abstract] [Full Text] [Related]

  • 24. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [Abstract] [Full Text] [Related]

  • 25. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 26. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients.
    Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L.
    Liver Transpl; 2004 Mar; 10(3):404-7. PubMed ID: 15004768
    [Abstract] [Full Text] [Related]

  • 27. Renal transplantation at the University of Wisconsin in the cyclosporine era.
    Knechtle SJ, Pirsch JD, D'Alessandro AM, Sollinger HW, Kalayoglu M, Belzer FO.
    Clin Transpl; 1993 Mar; ():211-8. PubMed ID: 7918154
    [Abstract] [Full Text] [Related]

  • 28. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Mar; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 29. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC, Berisa F, McGonigle RJ, Adu D, Michael J, Barnes AD.
    Nephrol Dial Transplant; 1989 Mar; 4(2):129-32. PubMed ID: 2496354
    [Abstract] [Full Text] [Related]

  • 30. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH, Porayko MK, Wahlstrom HE, Gores GJ, Kamath PS, Hay JE, Krom RA.
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract] [Full Text] [Related]

  • 31. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P.
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [Abstract] [Full Text] [Related]

  • 32. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC, Rohrer RM, Kaplan MM.
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [Abstract] [Full Text] [Related]

  • 33. [Rejection of a liver allograft. Diagnosis and treatment].
    Calmus Y.
    Ann Radiol (Paris); 1994 Aug; 37(5):377-82. PubMed ID: 7527621
    [Abstract] [Full Text] [Related]

  • 34. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR, Hastillo A, Goldman MH, Szentpetery S, Wolfgang TC, Mohanakumar T, Katz MR, Rider S, Hanrahan J, Lower RR.
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [Abstract] [Full Text] [Related]

  • 35. Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis.
    Manzia TM, Toti L, Angelico R, Di Cocco P, Orlando G, Tisone G.
    Transplant Proc; 2010 May; 42(4):1237-9. PubMed ID: 20534270
    [Abstract] [Full Text] [Related]

  • 36. Acute rejection: significance of elapsed time after transplantation.
    Rizeq MN, Masek MA, Billingham ME.
    J Heart Lung Transplant; 1994 May; 13(5):862-8. PubMed ID: 7803428
    [Abstract] [Full Text] [Related]

  • 37. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS, Reitz BA, Greene PS, Augustine S, Baumgartner WA.
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [Abstract] [Full Text] [Related]

  • 38. Benefits of avoidance of induction immunosuppression in heart transplantation.
    Menkis AH, McKenzie FN, Thomson D, Jones M, Pflugfelder P, Kostuk WJ, Stiller CR.
    J Heart Transplant; 1989 Nov; 8(4):311-4. PubMed ID: 2671316
    [Abstract] [Full Text] [Related]

  • 39. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC, Schroeder TJ, Pedersen SH, Dittrich VS, Balistreri WF.
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [Abstract] [Full Text] [Related]

  • 40. Clinical results of quadruple drug immunosuppression in liver transplantation.
    Fabregat J, Fradera R, Jaurrieta E, Figueras J, Rafecas A, Rufi G, Casanovas T, Casais L, Gil Vernet S.
    Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.